| Key Aspect | Details |
|---|---|
| Event | Signing of Letter of Intent (LoI) to establish Centre of Excellence for CRISPR Innovation and Translation (CoE-CIT) |
| Announcement Date | 22 December 2025 by Press Information Bureau |
| Partners | JNCASR (Bengaluru) (autonomous under DST) & CRISPRBITS Private Limited (Delhi) |
| Objective | Bridge gap between lab research & clinical applications (bench-to-bedside) |
| Focus Areas | - CRISPR-based gene editing <br> - Therapeutic solutions <br> - Affordable diagnostics & treatments |
| Significance | - First-of-its-kind PPP model in India <br> - Strengthens biotech & healthcare innovation <br> - Aligns with self-reliance in advanced tech |
| CRISPR Technology | - Enables precise DNA editing <br> - Applications in healthcare, biotech, diagnostics |
| Expected Impact | - Faster gene therapies <br> - Boosts academia-industry collaboration <br> - Affordable solutions for public health |
| Key Takeaway | CoE-CIT aims to translate lab research into real-world clinical benefits |
Workflow
Login
Contact Counsellor